Log In
Print this Print this

Dual orexin receptor antagonist (DORA)

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionDual orexin receptor antagonist
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationInsomnia
Indication DetailsTreat insomnia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today